Evaluation of the clinical efficacy of asenapine in schizophrenia
Authors:
- 20 May 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 11 (12) , 2107-2115
Abstract
(2010). Evaluation of the clinical efficacy of asenapine in schizophrenia. Expert Opinion on Pharmacotherapy: Vol. 11, No. 12, pp. 2107-2115.Keywords
This publication has 62 references indexed in Scilit:
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective DisorderPharmacopsychiatry, 2010
- AsenapineCNS Drugs, 2009
- Asenapine effects in animal models of psychosis and cognitive functionPsychopharmacology, 2009
- Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophreniaPharmacology & Therapeutics, 2009
- CNTRICS Final Task Selection: Control of AttentionSchizophrenia Bulletin, 2009
- Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS MeetingSchizophrenia Bulletin, 2008
- Realistic expectations of prepulse inhibition in translational models for schizophrenia researchPsychopharmacology, 2008
- Principles of Antipsychotic Prescribing for Policy Makers, Circa 2008. Translating Knowledge to Promote Individualized TreatmentSchizophrenia Bulletin, 2008
- Upcoming Agents for the Treatment of SchizophreniaDrugs, 2008
- Binding of antipsychotic drugs to human brain receptorsLife Sciences, 2000